CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Revenues	$ 983,705	$ 1,981,872	$ 1,146,290
Expenses:
Cost of sales	343,768	902,639	0
Research and development	737,502	1,235,278	2,534,508
Selling, general, and administrative	468,946	488,691	298,358
Total expenses	1,550,216	2,626,608	2,832,866
Loss from operations	(566,511)	(644,736)	(1,686,576)
Other income (expense):
Interest expense	(14,416)	(19,880)	(21,127)
Other income (expense)	37,896	10,969	(6,833)
Loss before income tax expense	(543,031)	(653,647)	(1,714,536)
Income tax expense	(2,031)	(4,292)	(29,215)
Net loss	$ (545,062)	$ (657,939)	$ (1,743,751)
Net loss per share:
Basic (in usd per share)	$ (5.41)	$ (8.42)	$ (23.44)
Diluted (in usd per share)	$ (5.41)	$ (8.42)	$ (23.44)
Weighted average number of common shares outstanding:
Basic (in shares)	100,768	78,183	74,400
Diluted (in shares)	100,768	78,183	74,400
Product sales
Revenue:
Revenues	$ 531,389	$ 1,554,961	$ 0
Grants
Revenue:
Revenues	427,323	382,921	948,709
Royalties and other
Revenue:
Revenues	$ 24,993	$ 43,990	$ 197,581